In a recent study published in the journal JAMA Neurology, researchers reviewed the progress thus far in pharmacologically managing the various neuropsychiatric syndromes that manifest in ...
Two proteins found on the surface of motor neurons in the brain may be essential in the progression of Parkinson's disease, ...
State Rep. Kyle Mullins' father died from ALS in 2022. That loss motivated him to fight for neurodegenerative disease ...
IFLScience on MSN
Experimental Alzheimer’s drug could have the power to halt disease before symptoms even start
A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer's disease.
Mice with late-stage symptoms showed improvement in memory loss and reduced brain plaque after experimental treatment, ...
Researchers have described the neurodegeneration that occurs in the nervous system of the bowel in Batten disease, a rare and fatal genetic condition. In their latest study, a team showed that gene ...
Scientists at Johns Hopkins Medicine say results of a new study are advancing efforts to exploit a new target for Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback